11 June, 2024
0 Comments
1 category
Chicago – First-generation angiogenic tyrosine kinase inhibitors have made significant progress in the treatment of advanced renal cell carcinoma for the first time. With immune checkpoint inhibitors in combination with next-generation angiogenesis inhibitors,… [weiter lesen]
#Advanced #renal #cell #carcinoma #immunotherapy #tyrosine #kinase #inhibitor #effective #long #term
Category: Medical Encyclopedia